A century of cholesterol and coronaries: from plaques to genes to statins.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25815993.
- Also identified by DOI 10.1016/j.cell.2015.01.036 and PMC identifier 4525717.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Medical subject headings
- Cholesterol
- Coronary Vessels
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Plaque, Atherosclerotic